Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.97% |
| 3 | Financials | 6.13% |
| 4 | Consumer Discretionary | 5.62% |
| 5 | Industrials | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
Vanguard International High Dividend Yield ETF
VYMI
$20.9B
| $504K | ﹤0.01% |
+8,136
| New | +$508K |
|
4527
Pixelworks
PXLW
$40.6M
| $503K | ﹤0.01% |
28,298
-12,867
| -31% | -$271K |
|
4528
Abeona Therapeutics
ABEO
$403M
| $502K | ﹤0.01% |
177,955
+30,176
| +20% | +$78.9K |
|
|
EU
4529
enCore Energy
EU
$237M
| $501K | ﹤0.01% |
+226,762
| New | +$514K |
|
4530
PUT
Plug Power
PLUG
$2.92B
| $498K | ﹤0.01% |
42,500
+31,800
| +297% | +$455K |
|
4531
CALL
Tyson Foods
TSN
$20.4B
| $498K | ﹤0.01% |
8,400
-11,200
| -57% | -$688K |
|
|
IMOS
4532
ChipMOS TECHNOLOGIES
IMOS
$1.85B
| $496K | ﹤0.01% |
+19,747
| New | +$462K |
|
4533
LeMaitre Vascular
LMAT
$1.83B
| $495K | ﹤0.01% |
+9,616
| New | +$467K |
|
|
MRCC
4534
DELISTED
Monroe Capital Corp
MRCC
| $495K | ﹤0.01% |
64,648
-41,846
| -39% | -$340K |
|
4535
Oxford Square Capital
OXSQ
$158M
| $494K | ﹤0.01% |
156,310
-292,696
| -65% | -$995K |
|
|
MACK
4536
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $494K | ﹤0.01% |
40,204
+23,219
| +137% | +$273K |
|
4537
Pampa Energía
PAM
$4.44B
| $493K | ﹤0.01% |
14,945
-223,194
| -94% | -$7.25M |
|
4538
Aclaris Therapeutics
ACRS
$865M
| $492K | ﹤0.01% |
60,863
-147,035
| -71% | -$1.87M |
|
4539
BioAtla
BCAB
$5.56M
| $492K | ﹤0.01% |
3,674
+1,633
| +80% | +$294K |
|
|
LIAN
4540
DELISTED
LianBio American Depositary Shares
LIAN
| $490K | ﹤0.01% |
251,495
-69,023
| -22% | -$143K |
|
4541
Crescent Capital BDC
CCAP
$432M
| $488K | ﹤0.01% |
35,846
-53,645
| -60% | -$777K |
|
4542
Otis Worldwide
OTIS
$28.2B
| $488K | ﹤0.01% |
5,781
-77,550
| -93% | -$6.42M |
|
|
PMT
4543
PennyMac Mortgage Investment
PMT
$837M
| $488K | ﹤0.01% |
39,564
-255,951
| -87% | -$3.44M |
|
4544
Global X Lithium & Battery Tech ETF
LIT
$1.59B
| $487K | ﹤0.01% |
+7,668
| New | +$495K |
|
4545
Renasant Corp
RNST
$3.94B
| $487K | ﹤0.01% |
15,927
-493,040
| -97% | -$17.2M |
|
4546
Comtech Telecommunications
CMTL
$52.4M
| $486K | ﹤0.01% |
38,976
-12,179
| -24% | -$174K |
|
|
HARP
4547
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $486K | ﹤0.01% |
65,282
-58,347
| -47% | -$491K |
|
4548
iShares MSCI New Zealand ETF
ENZL
$83.3M
| $485K | ﹤0.01% |
+9,714
| New | +$486K |
|
4549
PUT
Intuitive Surgical
ISRG
$132B
| $485K | ﹤0.01% |
1,900
-248,100
| -99% | -$61.1M |
|
4550
Astrana Health
ASTH
$1.81B
| $485K | ﹤0.01% |
+13,290
| New | +$465K |
|
Similar funds
Millennium Management's Q1 2023 Portfolio in Review
As of Q1 2023, Millennium Management held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Millennium Management withdrew a net $18.1B in Q1 2023, closing 1,209 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in Warner Bros worth $96.9M.
- Millennium Management's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Millennium Management added most to Linde in Q1 2023, an estimated $374M increase.
- Millennium Management's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Millennium Management fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Millennium Management's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Millennium Management opened 987 new positions and closed 1,209 in Q1 2023.
- Millennium Management's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.